Professor, Surgery, Washington University School of Medicine

General Surgery

Doctor John E. Mazuski, MD is an expert in the field of General Surgery. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine He received 2 awards: "Fellow (FCCM)" and "Fellow (FACS)". John Mazuski is a published doctor as well. He has 71 publications published. The latest was: Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. John Mazuski accepts Medicare.

Publications

---

• Prevalence of qacA/B Genes and Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates in the Setting of Chlorhexidine Bathing Without M...
• A Descriptive Study of the Risk Factors Associated with Catheter-Related Bloodstream Infections in the Home Parenteral Nutrition Population.
• Overview of severe Clostridium difficile infection.
• Current strategies for the treatment of complicated intraabdominal infections.
• Simultaneous Necrotizing Soft Tissue Infection and Colonic Necrosis Caused by Clostridium septicum.
• Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Soci...
• Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices.
• Antimicrobial therapy for acute colonic diverticulitis.
• Prevention of surgical site infection.
• The problem of infection has been inextricably linked with surgical therapy. Preface.
• The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit.
• Vancomycin-resistant enterococcus: risk factors, surveillance, infections, and treatment.
• Feeding the injured intestine: enteral nutrition in the critically ill patient.
• Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation ...
• Efficacy and safety of an insulin infusion protocol in a surgical ICU.
• Evaluation of the applicability, efficacy, and safety of a thromboembolic event prophylaxis guideline designed for quality improvement of the traumatically injured pat...
• Outcome after colectomy for Clostridium difficile colitis.
• Multiple organ failure in trauma patients.
• Intensive insulin therapy in critically ill patients.
• Aminoglycosides for intra-abdominal infection: equal to the challenge?
• Management of blunt hepatic injuries.
• Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
• Hypermetabolism/organ failure: the role of the activated macrophage as a metabolic regulator.
• Nitrogen retention in critically ill patients is proportional to the branched chain amino acid load.
• Right ventricular end-diastolic volume as a measure of preload.
• Role of cytoplasmic and secretory phospholipase A2 in intestinal epithelial cell prostaglandin E2 formation.
• Clostridium difficile toxins influence hepatocyte protein synthesis through the interleukin 1 receptor.
• The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells.
• Role of cytosolic phospholipase A2 in cytokine-stimulated prostaglandin release by human gallbladder cells.
• Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
• Overuse of splenic scoring and computed tomographic scans.
• Endotoxin stimulates hepatocyte interleukin-6 production.
• The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells.
• Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
• Evaluation of the thoracic and lumbar spine after blunt trauma.
• Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress.
• Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1.
• Direct effects of endotoxin on hepatocytes. Synthesis of a specific secretory protein.
• Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cells.
• Role of monokines in altering hepatic metabolism in sepsis.
• Nutritional pharmacology: its role in the hypermetabolism-organ failure syndrome.
• Omega 3 polyunsaturated fatty acids as modulators of cellular function in the critically ill.
• Hepatic acute phase protein synthesis is indirectly regulated by tumor necrosis factor.
• The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation.
• The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
• The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation.
• In vitro effects of Clostridium difficile toxins on hepatocytes.
• Effects of cytokine antagonists on the hepatic acute-phase response.
• Management of selected rectal injuries by primary repair.
• Outcome and utility of scoring systems in the management of the mangled extremity.
• Selective management of embolized intracardiac missiles.
• The use of oxygen consumption and delivery as endpoints for resuscitation in critically ill patients.
• Clinical trials of new and novel therapeutic agents.
• Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.
• Trauma management in the 21st century.
• The unreliability of CT scans and initial chest radiographs in evaluating blunt trauma induced diaphragmatic rupture.
• Traumatic train injuries.
• Right coronary artery occlusion secondary to blunt trauma.
• Acute acalculous cholecystitis in the critically ill.
• Computed tomography as a screening exam in patients with suspected blunt aortic injury.
• Computed tomography in the diagnosis of blunt thoracic injury.
• The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations.
• The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary.
• Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.
• Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.
• Comparison of forehead and digit oximetry in surgical/trauma patients at risk for decreased peripheral perfusion.
• Intra-abdominal sepsis: newer interventional and antimicrobial therapies.
• Clinical practice guidelines for the maintenance of patient physical safety in the intensive care unit: use of restraining therapies--American College of Critical Care...
• The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.
• Antimicrobial treatment for intra-abdominal infections.

Schools

---

• University of California At Los Angeles

• University Of Minnesota

Doctors Specialties

---

• Critical Care Surgery
• General Surgery

Accepted Insurances

---

Awards

---

• Fellow (FCCM)
• Fellow (FACS)

Education

---

• University of Minnesota at Fairview
• David Geffen School of Medicine at UCLA

Hospital

---

• Barnes-Jewish Hospital

Drug Facts

---

NPI NUMBER		1992723472
NPPES Provider LastName		MAZUSKI
NPPES Provider FirstName		JOHN
NPPES Provider ZIPCode		631101003
NPPES Provider State		MO
Specialty Description		General Surgery
Total Claim Count		22.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1992723472
Last Name Of The Provider	MAZUSKI
First Name Of The Provider	JOHN
View All

Similar Doctors

---

	Dr. John P. Kirby III, MD
	Dr. Brian Holt, MD
	Dr. Jeffrey A. Lowell, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry M. Altepeter, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel J. Naughton, MD This Doctor is OpenDoctor Recommended.
	Dr. Harold E. Dunn, MD
	Dr. Klark Exarhou, MD
	Dr. Jessica L. Hudson, MD
	Dr. Matthew T. Ricks, DO
	Dr. Mark E. McMellen, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert Schmieg, MD
	Dr. Yifei A. Sun, MD This Doctor is OpenDoctor Recommended.
	Dr. Sai R. Velamuri, MD
	Dr. Lauren K. Muckleroy, MD
	Dr. John P. Hoehn III, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog